Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by DAN, M.
Right arrow Articles by BAR-SHANY, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DAN, M.
Right arrow Articles by BAR-SHANY, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1992 Oxford University Press

research-article

Human Immunodeficiency Virus Infection among Intravenous Drug Addicts in Israel—Stable Low Prevalence over 34 Months

MICHAEL DAN, ALEX CAHANA, YORAM FINTSI and SHULAMIT BAR-SHANY

The Infectious Diseases Unit, The E Wolfson Hospital Holon 58100, and MDA Blood Services, Tel-Hashomer, Israel

A serological survey of 300 Israeli intravenous drug addicts in 1988–1989, showed a 2.3% prevalence of antibodies to human immunodeficiency virus (HIV), very similar to the finding of a previous study (2%) performed in the same population in 1986. Travel and drug injection abroad continue to be the most significant predictors of HIV seropositivity in this group. The relatively uncommon use of cocaine and the absence of ‘shooting galleries’ in Israel, appears to explain best the stable low prevalence of HIV infection among parenteral drug addicts in this country.

Received 1 December 1991


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.